PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

NHS gene testing fails half of people at cancer risk

A new study has revealed that NHS guidelines for gene testing miss half of people carrying inherited genetic changes linked to cancer. The Institute of Cancer Res...
Continue Reading →
News

Data day: Trial results deliver hope for prostate cancer patients

New combination treatment can significantly reduce the risk of death among prostate cancer patients A pivotal Phase 3 trial has shown that a new combination treat...
Continue Reading →
News

All trades: Syncona announces sale of portfolio company to Novartis

Syncona – a company focused on founding, building and funding global leaders in life science – has announced the sale of its portfolio company, Gyroscope Therapeutic...
Continue Reading →
News

Seal of Approval: Direct-to-PCR COVID-19 test in the UK validated

First direct-to-PCR test added to the CTDA register of approved UK products Novacyt – an international specialist in clinical diagnostics – has announced that the...
Continue Reading →
News

Moderna’s commercial network grows

Vaccine pioneers expand presence throughout Europe with a view to leveraging technology The biotechnology company, Moderna, has announced plans to expand its comm...
Continue Reading →
News

Alexion and UK patient advocacy groups launch video campaign

Rare Disease Day has inspired a pioneering video to support patients living with rare conditions Alexion Pharma UK has launched a new video titled–‘Reforming Rare...
Continue Reading →
News

AstraZeneca pledges more Evusheld doses to US, bringing its antibody supply deal to $855M

That was fast: A little more than a month after AstraZeneca sold the U.S. half a million doses of its COVID-19 antibody combo, the British drugmaker and U.S. officia...
Continue Reading →
News

FDA signs off on Lilly’s new antibody drug, bebtelovimab, which is effective against the omicron variant

One day after the United States announced a supply deal for Eli Lilly’s new COVID-19 monoclonal antibody treatment, bebtelovimab, the FDA granted it emergency use au...
Continue Reading →
News

Pfizer and Lilly’s JAK inhibitor safety concerns prompt Europe to scrutinize drug class

The risk of heart-related issues accompanying the use of JAK inhibitors has brought the entire drug class under scrutiny. Last September, the FDA said it will requir...
Continue Reading →
News

FDA sets an example through Eli Lilly, Innovent’s PD-1, rocking the boat for future contenders: analyst

By making an example of Eli Lilly and partner Innovent Biologics’ practically denied application for PD-1 inhibitor Tyvyt, the FDA is sounding the alarm for com...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026